NCT01326468 Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer Status WITHDRAWN Phase NA
NCT01326000 A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01317433 Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer Status TERMINATED Phase NA
NCT01316757 Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2
NCT01309126 Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Status TERMINATED Phase PHASE3
NCT01302834 Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Status COMPLETED Phase PHASE3
NCT01294826 Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01292356 Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response Status COMPLETED Phase PHASE2
NCT01287130 AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01283334 A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01280643 Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status TERMINATED Phase NA
NCT01276379 Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab Status COMPLETED Phase PHASE2
NCT01271439 Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE2
NCT01256385 Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy Status COMPLETED Phase PHASE2
NCT01254617 Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT01230476 Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma Status TERMINATED Phase PHASE2
NCT01228734 A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients Status COMPLETED Phase PHASE3
NCT01225744 Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy Status COMPLETED Phase PHASE2
NCT01221753 Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study Status TERMINATED Phase PHASE2